Ito, S., Oyake, T., Murai, K., & Ishida, Y. Successful Use of Cyclophosphamide as an Add-On Therapy for Multiple Myeloma Patients with Acquired Resistance to Bortezomib or Lenalidomide. Wiley.
Chicago Style (17th ed.) CitationIto, Shigeki, Tatsuo Oyake, Kazunori Murai, and Yoji Ishida. Successful Use of Cyclophosphamide as an Add-On Therapy for Multiple Myeloma Patients with Acquired Resistance to Bortezomib or Lenalidomide. Wiley.
MLA (9th ed.) CitationIto, Shigeki, et al. Successful Use of Cyclophosphamide as an Add-On Therapy for Multiple Myeloma Patients with Acquired Resistance to Bortezomib or Lenalidomide. Wiley.
Warning: These citations may not always be 100% accurate.